Date Added: Dec 2009
When conceptualizing modern biotechnology, Brink et al. (2004) suggest that a distinction should be made between 'Core' biotechnology and associated sectors like pharmaceuticals, medical technologies, agriculture and food. Dedicated Biotechnology Firms (DBFs) are generally seen as the main actors that represent the 'Core' of modern biotechnology. A DBF is defined as a firm whose predominant activity involves the application of biotechnology techniques to produce goods or services and/or the performance of biotechnology research and development (OECD, 2005).